Skip to main content
. 2022 Jan 13;43(5):977–985. doi: 10.1007/s00246-021-02807-7

Fig. 1.

Fig. 1

Provider indications for initiating cardiac therapy by medication class: a Angiotensin converting enzyme inhibitor/angiotensin receptor blocker; b Beta-blocker; c Aldosterone antagonist. ACEi Angiotensin converting enzyme inhibitor, ARB Angiotensin receptor blocker, LGE Late gadolinium enhancement